Subsequently, we demonstrated that LCC-09, by targeting DRD4 dopaminergic signals and ALDH activity, induces marked attenuation of the stem cell-like phenotype of GBM cells (Figure 4). The gene discussed is LDHA; the disease is glioblastoma.